Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
| Reduction to sales and marketing expense | $ (19,815) | $ (19,446) |
| Cost of goods sold increase (decrease) | 8,758 | 8,172 |
| General and administrative | 9,956 | 10,061 |
| Decrease in research and development | (7,409) | (6,326) |
| Cash and cash equivalents balance outside of FDIC limit | $ 14,963 | |
| Revision of Prior Period, Reclassification, Adjustment | ||
| Reduction to sales and marketing expense | 707 | |
| Cost of goods sold increase (decrease) | (2) | |
| General and administrative | 1,062 | |
| Decrease in research and development | 353 | |
| Shipping and Handling | Revision of Prior Period, Change in Accounting Principle, Adjustment | ||
| Reduction to sales and marketing expense | 1,465 | |
| Cost of goods sold increase (decrease) | $ 1,465 | |
| X | ||||||||||
- Definition The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|